Home The Word Brain	My Amedeo FAQ Privacy About
	2049 Chinese The 20K Word Road to Mandarin Proficiency By B. S. Kamps et al.

Leukemia

Free Subscription Articles published in Br J Cancer Retrieve available abstracts of 23 articles: HTML format

Single Articles

March 2024
1. LITTLE MP, Eidemuller M, Kaiser JC, Apostoaei AI, et al
   Minimum latency effects for cancer associated with exposures to radiation or other carcinogens.
   Br J Cancer. 2024;130:819-829.
   PubMed     Abstract available
   
   
   February 2024
2. ZAKKAK N, Barclay ME, Swann R, McPhail S, et al
   The presenting symptom signatures of incident cancer: evidence from the English 2018 National Cancer Diagnosis Audit.
   Br J Cancer. 2024;130:297-307.
   PubMed     Abstract available
   
   
   
3. GUTIERREZ-CAMINO A, Richer C, Ouimet M, Fuchs C, et al
   Characterisation of FLT3 alterations in childhood acute lymphoblastic leukaemia.
   Br J Cancer. 2024;130:317-326.
   PubMed     Abstract available
   
   
   January 2024
4. HEYMER EJ, Hawkins MM, Winter DL, Teepen JC, et al
   Risk of subsequent gliomas and meningiomas among 69,460 5-year survivors of childhood and adolescent cancer in Europe: the PanCareSurFup study.
   Br J Cancer. 2024 Jan 19. doi: 10.1038/s41416-024-02577.
   PubMed     Abstract available
   
   
   October 2023
5. LITTLE MP, Wakeford R, Zablotska LB, Borrego D, et al
   Radiation exposure and leukaemia risk among cohorts of persons exposed to low and moderate doses of external ionising radiation in childhood.
   Br J Cancer. 2023;129:1152-1165.
   PubMed     Abstract available
   
   
   September 2023
6. LORENZINI T, Cadilha BL, Obeck H, Benmebarek MR, et al
   Rational design of PD-1-CD28 immunostimulatory fusion proteins for CAR T cell therapy.
   Br J Cancer. 2023;129:696-705.
   PubMed     Abstract available
   
   
   July 2023
7. GUPTA DG, Varma N, Sreedharanunni S, Abdulkadir SA, et al
   'Evaluation of adverse prognostic gene alterations & MRD positivity in BCR::ABL1-like B-lineage acute lymphoblastic leukaemia patients, in a resource-constrained setting.
   Br J Cancer. 2023;129:143-152.
   PubMed     Abstract available
   
   
   June 2023
8. BEDICS G, Egyed B, Kotmayer L, Benard-Slagter A, et al
   PersonALL: a genetic scoring guide for personalized risk assessment in pediatric B-cell precursor acute lymphoblastic leukemia.
   Br J Cancer. 2023 Jun 21. doi: 10.1038/s41416-023-02309.
   PubMed     Abstract available
   
   
   May 2023
9. CROMIE KJ, Hughes NF, Milner S, Crump P, et al
   Socio-economic and ethnic disparities in childhood cancer survival, Yorkshire, UK.
   Br J Cancer. 2023;128:1710-1722.
   PubMed     Abstract available
   
   
   March 2023
10. LIU HC, Kuo MC, Wu KH, Chen TY, et al
    Children with chronic myeloid leukaemia treated with front-line imatinib have a slower molecular response and comparable survival compared with adults: a multicenter experience in Taiwan.
    Br J Cancer. 2023;128:1294-1300.
    PubMed     Abstract available
    
    
    February 2023
11. WANG L, Zhang Q, Ye L, Ye X, et al
    All-trans retinoic acid enhances the cytotoxic effect of decitabine on myelodysplastic syndromes and acute myeloid leukaemia by activating the RARalpha-Nrf2 complex.
    Br J Cancer. 2023;128:691-701.
    PubMed     Abstract available
    
    
    November 2022
12. SUNGUC C, Hawkins MM, Winter DL, Dudley IM, et al
    Risk of subsequent primary oral cancer in a cohort of 69,460 5-year survivors of childhood and adolescent cancer in Europe: the PanCareSurFup study.
    Br J Cancer. 2022 Nov 1. pii: 10.1038/s41416-022-02016.
    PubMed     Abstract available
    
    
    September 2022
13. VENN NC, Huang L, Hovorkova L, Muskovic W, et al
    Measurable residual disease analysis in paediatric acute lymphoblastic leukaemia patients with ABL-class fusions.
    Br J Cancer. 2022;127:908-915.
    PubMed     Abstract available
    
    
    July 2022
14. SELLIN M, Mack R, Rhodes MC, Zhang L, et al
    Molecular mechanisms by which splice modulator GEX1A inhibits leukaemia development and progression.
    Br J Cancer. 2022;127:223-236.
    PubMed     Abstract available
    
    
    February 2022
15. JIANG Y, Southam AD, Trova S, Beke F, et al
    Valproic acid disables the Nrf2 anti-oxidant response in acute myeloid leukaemia cells enhancing reactive oxygen species-mediated killing.
    Br J Cancer. 2022;126:275-286.
    PubMed     Abstract available
    
    
    
16. SUBHASH VV, Huang L, Kamili A, Wong M, et al
    Whole-genome sequencing facilitates patient-specific quantitative PCR-based minimal residual disease monitoring in acute lymphoblastic leukaemia, neuroblastoma and Ewing sarcoma.
    Br J Cancer. 2022;126:482-491.
    PubMed     Abstract available
    
    
    September 2021
17. TARIQ MU, Furqan M, Parveen H, Ullah R, et al
    CCT245718, a dual FLT3/Aurora A inhibitor overcomes D835Y-mediated resistance to FLT3 inhibitors in acute myeloid leukaemia cells.
    Br J Cancer. 2021;125:966-974.
    PubMed     Abstract available
    
    
    July 2021
18. MOGENSEN H, Modig K, Talback M, Erdmann F, et al
    Number of siblings and survival from childhood leukaemia: a national register-based cohort study from Sweden.
    Br J Cancer. 2021;125:112-118.
    PubMed     Abstract available
    
    
    
19. KARSA M, Kosciolek A, Bongers A, Mariana A, et al
    Exploiting the reactive oxygen species imbalance in high-risk paediatric acute lymphoblastic leukaemia through auranofin.
    Br J Cancer. 2021;125:55-64.
    PubMed     Abstract available
    
    
    May 2021
20. SONG S, Zhang J, Su Q, Zhang W, et al
    Downregulation of ITGA6 confers to the invasion of multiple myeloma and promotes progression to plasma cell leukaemia.
    Br J Cancer. 2021;124:1843-1853.
    PubMed     Abstract available
    
    
    February 2021
21. PINTO-FERNANDEZ A, Salio M, Partridge T, Chen J, et al
    Deletion of the deISGylating enzyme USP18 enhances tumour cell antigenicity and radiosensitivity.
    Br J Cancer. 2021;124:817-830.
    PubMed     Abstract available
    
    
    January 2021
22. BARROW TM, Nakjang S, Lafta F, Bilotkach K, et al
    Epigenome-wide analysis reveals functional modulators of drug sensitivity and post-treatment survival in chronic lymphocytic leukaemia.
    Br J Cancer. 2021;124:474-483.
    PubMed     Abstract available
    
    
    December 2020
23. PUETT RC, Poulsen AH, Taj T, Ketzel M, et al
    Relationship of leukaemias with long-term ambient air pollution exposures in the adult Danish population.
    Br J Cancer. 2020;123:1818-1824.
    PubMed     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Leukemia is free of charge.